Effects of the multi‐kinase inhibitor midostaurin in combination with chemotherapy in models of acute myeloid leukaemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effects of the multi‐kinase inhibitor midostaurin in combination with chemotherapy in models of acute myeloid leukaemia

Published:2020-01-22 Issue:5 Volume:24 Page:2968-2980
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Weisberg Ellen¹²^ORCID,Meng Chengcheng¹,Case Abigail E.¹,Tiv Hong L.³,Gokhale Prafulla C.³,Buhrlage Sara J.⁴,Yang Jing⁴,Liu Xiaoxi⁴,Wang Jinhua⁵,Gray Nathanael⁵,Adamia Sophia¹²,Sattler Martin¹²,Stone Richard¹²,Griffin James D.¹²

Affiliation:

1. Department of Medical Oncology Dana‐Farber Cancer Institute Boston MA USA

2. Department of Medicine Harvard Medical School Boston MA USA

3. Experimental Therapeutic Core Dana‐Farber Cancer Institute Harvard Medical School Boston MA USA

4. Department of Cancer Biology Dana‐Farber Cancer Institute Harvard Medical School Boston MA USA

5. Department of Biological Chemistry and Molecular Pharmacology Harvard Medical School Boston MA USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.14927

Reference42 articles.

1. The role of FLT3 in haematopoietic malignancies

2. Clinical implications of c-Kit mutations in acute myelogenous leukemia

3. Activating loop mutations in the PDGFR α and β genes are rare in core binding factor acute myeloid leukaemia

4. Novel missense mutations in the tyrosine kinase domain of the platelet-derived growth factor receptor α(PDGFRA) gene in childhood acute myeloid leukemia with t(8;21)(q22;q22) or inv(16)(p13q22)

5. Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transplant Eligible and Ineligible Elderly Patients with AML—A Genomic Approach and Next Generation Questions;Biomedicines;2024-04-29

2. A Phase I Trial of Sirolimus with “7&3” Induction Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia;Cancers;2023-10-25

3. Phytochemicals and bioactive compounds effective against acute myeloid leukemia: A systematic review;Food Science & Nutrition;2023-05-15

4. Midostaurin – the First Targeted Therapy Drug for Patients with Acute Myeloid Leukaemia with FLT3 Mutation;Acta Poloniae Pharmaceutica - Drug Research;2023-03-03

5. The spleen tyrosine kinase (SYK): A crucial therapeutic target for diverse liver diseases;Heliyon;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3